HIMS & HERS HEALTH INC (HIMS) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
34.7 USD
-0.35 (-1%)
ChartMill assigns a Buy % Consensus number of 68% to HIMS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.53. This target is 36.98% above the current price.
HIMS was analyzed by 21 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about HIMS.
In the previous month the buy percentage consensus was at a similar level.
HIMS was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-04 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-04 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-10-21 | Keybanc | Initiate | Sector Weight |
| 2025-09-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-08-05 | Needham | Reiterate | Hold -> Hold |
| 2025-07-17 | Truist Securities | Maintains | Hold -> Hold |
| 2025-06-11 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-06-04 | Needham | Maintains | Buy -> Buy |
| 2025-05-06 | Needham | Reiterate | Buy -> Buy |
| 2025-05-06 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2025-05-06 | Citigroup | Maintains | Sell -> Sell |
| 2025-04-29 | TD Cowen | Downgrade | Buy -> Hold |
| 2025-04-29 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-04-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-25 | Citigroup | Maintains | Sell -> Sell |
| 2025-04-10 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-18 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-03-06 | B of A Securities | Reiterate | Underperform -> Underperform |
| 2025-03-06 | Citigroup | Reiterate | Sell -> Sell |
| 2025-02-26 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-25 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-02-25 | Needham | Maintains | Buy -> Buy |
| 2025-02-25 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-25 | Citigroup | Maintains | Sell -> Sell |
| 2025-02-20 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-02-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-18 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-01-10 | Citigroup | Downgrade | Neutral -> Sell |
HIMS & HERS HEALTH INC / HIMS FAQ
What is the average price target for HIMS & HERS HEALTH INC (HIMS) stock?
21 analysts have analysed HIMS and the average price target is 47.53 USD. This implies a price increase of 36.98% is expected in the next year compared to the current price of 34.7.
Can you provide the consensus rating for HIMS & HERS HEALTH INC stock?
The consensus rating for HIMS & HERS HEALTH INC (HIMS) is 67.619 / 100 . This indicates that analysts generally have a neutral outlook on the stock.